Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Heritable Pulmonary Arterial Hypertension

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Heritable Pulmonary Arterial Hypertension in 1 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huh, JW1
Kim, SY1
Lee, JH1
Lee, YS1

Other Studies

1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Heritable Pulmonary Arterial Hypertension

ArticleYear
YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
    Pulmonary pharmacology & therapeutics, 2011, Volume: 24, Issue:6

    Topics: Animals; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Endothelin-1; E

2011